Scientific Sessions 2024  /  Gene Therapy in the Cardiology Clinic: Ready for Prime Time?  /  Gene Silencing: Targeting TTR in Amyloidosis as a Paradigm for Knocking Down Mutant Alleles
Logo

American Heart Association

  14
  0

Final ID:

Gene Silencing: Targeting TTR in Amyloidosis as a Paradigm for Knocking Down Mutant Alleles

  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
  • Garcia-pavia, Pablo  ( Hospital Puerta de Hierro , Majadahonda , Spain )
    • Author Disclosures:
    Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:Prothena:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Intellia:Past (completed) ; Consultant:Alnylam:Active (exists now) | Pablo Garcia-Pavia: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Rocket Pharmaceuticals:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Consultant:Lexeo:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:BMS:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:ATTRalus:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:Bridgebio:Active (exists now) ; Consultant:Alnylam:Active (exists now) ; Consultant:Ionis:Active (exists now) ; Consultant:NovoNordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Gene Therapy in the Cardiology Clinic: Ready for Prime Time?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Gene Therapy in 2024: What Are the Options?

Helms Adam, Rosanno Joseph, Giacca Mauro

Gene Therapy for Lysosomal Storage Disorders: From the Bench to the Bedside

Adler Eric, Greenberg Barry

More abstracts from these authors:
Discussant: SCAN-MP

Alexander Kevin

Disparities in the Management and Outcomes of Cardiac Amyloidosis in Underrepresented Populations. -how can we bridge the gaps? 10 minutes

Bullock-palmer Renee, Alexander Kevin

You have to be authorized to contact abstract author. Please, Login
Not Available